关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nicpbp.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  4 9 9 2 3 0 4 位浏览者
您当前的位置:首页 >> 正文

口腔黏膜给药制剂的质量评价研究

Characterization methods for transmucosal drug delivery

分类号:R917
出版年·卷·期(页码):2019,39 (11):1980-1991
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

在非胃肠道给药系统中,口腔黏膜给药制剂由于具有便于服用及提高患者顺应性等优势,成为近年来研究较为广泛的给药途径。但目前各国上市的口腔黏膜制剂非常有限,很大程度上是由于缺乏统一的、符合口腔生理状况的质量评价体系。口腔黏膜制剂除考察制剂的理化特性外,还需评估与制剂有效性、安全性密切相关的黏附时间、黏附强度、黏膜渗透性、体外释放以及体内药动学特性。研究者对这些指标的评价方法各不相同,如离体组织可以是猪颊黏膜、犬口腔黏膜、鼠黏膜等;渗透性可通过Franz扩散池、Flow-through流通池、尤斯灌流室等方法进行检测,但不同的检测方法其结果各不相同,严重阻碍了口腔黏膜制剂的质量评价。本文综述了目前主要采用的评价方法,为制定一致的、合理的口腔黏膜剂质量评价提供理论基础。

-----英文摘要:---------------------------------------------------------------------------------------

Among the non-gastrointestinal routes, transmucosal drug delivery preparations have been extensive researched in recent years due to their advantages of being convenient to take and improving patient compliance.However, currently there are very limited oral mucosa preparations on the market in various countries, which is largely due to the lack of a unified quality evaluation system in line with the oral physiological conditions.In addition to the physical and chemical properties of the formulations, it is also necessary to evaluate the adhesion time, mucoadhesion strength, mucocal permeability, in vitro dissolution and pharmacokinetic properties which are closely related to their efficacy and safety.The evaluation methods of these indicators vary from researcher to researcher.For example, in vitro buccal tissues can be from pigs, dogs, mouse, etc.In vitro permeability can be detected by Franz diffusion cell, flow-through diffusion cell and Ussing chambers, but the results of different detection methods are different, which seriously hinder the quality evaluation of oral mucosa preparations.Thus this article reviews the current characterization methods and provides a theoretical basis for the development of standardized quality evaluation methods.

-----参考文献:---------------------------------------------------------------------------------------

[1] FONSECA-SANTOS B,CHORILLI M.An overview of polymeric dosage forms in buccal drug delivery:state of art,design of formulations and their in vivo performance evaluation[J].Mater Sci Eng C,2018,86:129
[2] HOFFMANN A,DANIELS R.A novel test system for the evaluation of oral mucoadhesion of fast disintegrating tablets[J].Int J Pharm,2018,551(1/2):141
[3] PARODI B,RUSSO E,BALDASSARI S,et al.Development and characterization of a mucoadhesive sublingual formulation for pain control:extemporaneous oxycodone films in personalized therapy[J].Drug Dev Ind Pharm,2017,43(6):917
[4] SALEHI S,BODDOHI S.New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate[J].Prog Biomater,2017,6(4):175
[5] BATISTA P,CASTRO P,MADUREIRA AR,et al.Development and characterization of chitosan microparticles-in-films for buccal delivery of bioactive peptides[J].Pharmaceuticals,2019, 12(1):1
[6] CELIK B.Risperidone mucoadhesive buccal tablets:formulation design,optimization and evaluation[J].Drug Des Devel Ther,2017,11:3355
[7] de CARO V,AJOVALASIT A,SUTERA FM,et al.Development and characterization of an amorphous solid dispersion of furosemide in the form of a sublingual bioadhesive film to enhance bioavailability[J].Pharmaceutics,2017,9(3):1
[8] TRASTULLO R,ABRUZZO A,SALADINI B,et al.Design and evaluation of buccal films as paediatric dosage form for transmucosal delivery of ondansetron[J].Eur J Pharm Biopharm,2016,105:115
[9] ZHANG CL,LIU YA,LI W,et al.Mucoadhesive buccal film containing ornidazole and dexamethasone for oral ulcers:in vitro and in vivo studies[J].Pharm Dev Technol,2019,24(1):118
[10] LAFFLEUR F,SCHMELZLE F,GANNER A,et al.In vitro and ex vivo evaluation of novel curcumin-loaded excipient for buccal delivery[J].AAPS PharmSciTech,2017,18(6):2102
[11] TAKEUCHI I,KAMIKI Y,MAKINO K.Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy[J].Colloid Surface B,2018,167:468
[12] DA SILVA JB,KHUTORYANSKIY VV,BRUSCHI ML,et al.A mucosa-mimetic material for the mucoadhesion testing of thermogelling semi-solids[J].Int J Pharm,2017,528(1/2):586
[13] NAIR AB,KUMRIA R,HARSHA S,et al.In vitro techniques to evaluate buccal films[J].J Control Release,2013,166(1):10
[14] WONG CF,YUEN KH,PEH KK.An in-vitro method for buccal adhesion studies:importance of instrument variables[J].Int J Pharm,1999,180(1):47
[15] ANSARI M,SADARANI B,MAJUMDAR A.Optimization and evaluation of mucoadhesive buccal films loaded with resveratrol[J].J Drug Deliv Sci Technol,2018,44:278
[16] RAAFAT AI,MAHMOUD GA,ALI AE-H,et al.In vitro evaluation of mucoadhesive and self-disinfection efficiency of(acrylic acid/polyethylene glycol)-silver nanocomposites for buccal drug delivery[J].J Bioact Compat Pol,2017,33(1):95
[17] SA GL,XIONG XP,WU TF,et al.Histological features of oral epithelium in seven animal species:as a reference for selecting animal models[J].Eur J Pharm Sci,2016,81:10
[18] SATTAR M,LANE ME.Oral transmucosal delivery of naratriptan[J].Int J Pharm,2016,514(1):263
[19] MURA P,ORLANDINI S,CIRRI M,et al.A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption[J].Int J Pharm,2018,547(1/2):530
[20] COOK MT,SMITH SL,KHUTORYANSKIY V.Novel glycopolymer hydrogels as mucosa-mimetic materials to reduce animal testing[J].Chem Commun,2015,51(77):14447
[21] BIBI HA,HOLM R,BAUER-BRANDL A.Use of Permeapad for prediction of buccal absorption:a comparison to in vitro,ex vivo and in vivo method[J].Eur J Pharm Sci,2016,93:399
[22] YANG Z,SOTTHIVIRAT S,WU Y,et al.Application of in vitro transmucosal permeability,dose number,and maximum absorbable dose for biopharmaceutics assessment during early drug development for intraoral delivery[J].Int J Pharm,2016,503(1/2):78
[23] MARXEN E,MOSGAARD MD,PEDERSEN AML,et al.Mucin dispersions as a model for the oromucosal mucus layer in in vitro and ex vivo buccal permeability studies of small molecules[J].Eur J Pharm Biopharm,2017,121:121
[24] PALEM CR,KUMAR BATTU S,GANNU R,et al.Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery:in vitro and ex vivo characterization[J].Pharm Dev Technol,2012,17(3):321
[25] JAGER J,OBST K,LOHAN SB,et al.Characterization of hyperbranched core-multishell nanocarriers as an innovative drug delivery system for the application at the oral mucosa[J].J Periodontal Res,2018,53(1):57
[26] CRDOBA-DAZ M,NOVA M,ELORZA B,et al.Validation protocol of an automated in-line flow-through diffusion equipment for in vitro permeation studies[J].J Control Release,2000,69(3):357
[27] LESTARI ML,NICOLAZZO JA,FINNIN BC.A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro[J].J Pharm Sci,2009,98(12):4577
[28] KOLLI CS,PATHER I.Characterization Methods for Oral Mucosal Drug Delivery[M]//RATHBONE MJ,PATHER I,SENEL S.Oral Mucosal Drug Delivery and Therapy.New Jersey:Controlled Release Society,2016:125
[29] NAZARI K,KONTOGIANNIDOU E,AHMAD RH,et al.Development and characterisation of cellulose based electrospun mats for buccal delivery of non-steroidal anti-inflammatory drug(NSAID)[J].Eur J Pharm Sci,2017,102:147
[30] MARQUES AC,ROCHA AI,LEAL P,et al.Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen[J].Int J Pharm,2017,533(2):455
[31] ROJEWSKA M,BARTKOWIAK A,MILANOWSKI B,et al.Physicochemical and release studies of new mucoadhesive fluconazole delivery systems[J].Colloid Surf A,2019,566:11
[32] ZENG N,SEGUIN J,DESTRUEL PL,et al.Cyanine derivative as a suitable marker for thermosensitive in situ gelling delivery systems:in vitro and in vivo validation of a sustained buccal drug delivery[J].Int J Pharm,2017,534(1/2):128
[33] OKAMOTO H,TAGUCHI H,IIDA K,et al.Development of polymer film dosage forms of lidocaine for buccal administration I.penetration rate and release rate[J].J Control Release,2001,77(3):253
[34] MENG-LUND E,JACOBSEN J,MLLERTZ A,et al.Buccal absorption of diazepam is improved when administered in bioadhesive tablets-an in vivo study in conscious Gottingen mini-pigs[J].Int J Pharm,2016,515(1/2):125
[35] RACHID O,SIMONS KJ,RAWAS-QALAJI M.In vivo evaluation of taste-masked fast-disintegrating sublingual tablets of epinephrine microcrystals[J].AAPS PharmSciTech,2018,19(8):3886
[36] BENVENGA S,DI BARI F.Intestinal absorption and buccal absorption of liquid levothyroxine[J].Endocrine,2017,58(3):591

欢迎阅读《药物分析杂志》!您是该文第 291位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn

本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838